logo

For the Inventor, By the Inventor

New York, NY, United States of America

Bioincept, LLC


USPTO Granted Patents = 19

% Expired Patents = 36.8



Forward Citations = 104

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Eytan R Barnea (19 out of 25 patents)

silverMedal Paul C Leavis (7 out of 11 patents)

bronzeMedal Ruben Rene Gonzales Perez (4 out of 4 patents)

4.  Ruben Rene Gonzalez Perez (2 out of 2 patents)

5.  Reuben Renee Gonzales Perez (1 out of 1 patent)

6.  Soren Bohos Hayrabedyan (0 patent)

7.  Ruben Rene Perez (0 patent)

8.  Ruben Renee Gonzalez Perez (0 patent)


19 patents:

1. 11096987 - Mutant peptides and methods of treating subjects using the same (2021-08-24),
2. 11090355 - Compositions and methods for the treatment of neurodamage (2021-08-17),
3. 11000566 - Compositions and methods for modulating the immune system (2021-05-11),
4. 10953071 - Compositions and methods for treatment of intracellular damage and bacterial infection (2021-03-23),
5. 10806771 - Compositions and methods for modulating the immune system (2020-10-20),
6. 10071131 - Compositions and methods for modulating the immune system (2018-09-11),
7. 9737585 - Compositions and methods for treatment of intracellular damage and bacterial infection (2017-08-22),
8. 9097725 - Compositions and methods for modulating the immune system (2015-08-04),
9. 8454967 - Compositions and methods for modulating the immune system (2013-06-04),
10. 8222211 - Methods of administering PIF agonist peptides and uses thereof (2012-07-17),
11. 8012700 - Assays for preimplantation factor and preimplantation factor peptides (2011-09-06),
12. 7723290 - Compositions and methods for modulating the immune system (2010-05-25),
13. 7723289 - PIF tetrapeptides (2010-05-25),
14. 7695977 - Assays for preimplantation factor and preimplantation factor peptides (2010-04-13),
15. 7678582 - Assays for preimplantation factor and preimplantation factor peptides (2010-03-16),
Company Overview
Bioincept, LLC is a biotechnology company based in New York, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing treatments that leverage proprietary technologies to address unmet medical needs. With a commitment to research and development, Bioincept aims to enhance patient outcomes through its cutting-edge approaches in drug formulation and delivery. The company is dedicated to fostering collaborations that drive scientific progress and improve healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#419 in New York, NY

#1,006 in New York

#17,138 in US

#32,663 in the World

New York, NY (US)
New York, NY, United States of America

Bioincept, LLC

Forward Citations = 104

5 inventors:

goldMedal Eytan R Barnea (19 out of 25 patents)

silverMedal Paul C Leavis (7 out of 11 patents)

bronzeMedal Ruben Rene Gonzales Perez (4 out of 4 patents)

4.  Ruben Rene Gonzalez Perez (2 out of 2 patents)

5.  Reuben Renee Gonzales Perez (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioincept, LLC. Retrieved from https://idiyas.com/company/bioincept

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…